TrialWorld journal of urology2024

Tumor regression after neoadjuvant hormonal therapy in high risk prostate cancer: pathological outcomes from a randomized phase II trial.

Leonardo Cardili et al.PubMed ↗Publisher ↗

No numbers read from the abstract.